Molecular and Cellular Biology · 2003 · 410 citations · 48 references
Life SciencesCell BiologyMolecular BiologyApoptosisCell SignalingSignal TransductionApoptosis RegulationApoptotic Signal TransductionApoptotic SignalingCell DeathDeath ReceptorsExtrinsic Apoptotic PathwayApoptosis Signaling ComplexesDeath-inducing Signaling Complex AssemblyFas LigandFas Ligand-mediated ApoptosisFas-fas Ligand Mediated KillingIntracellular Signaling PathwaysOligomerizationReceptor-mediated Apoptosis
The membrane-bound form of Fas ligand (FasL) signals apoptosis in target cells through engagement of the death receptor Fas, whereas the proteolytically processed, soluble form of FasL does not induce cell death. However, soluble FasL can be rendered active upon cross-linking. Since the minimal extent of oligomerization of FasL that exerts cytotoxicity is unknown, we engineered hexameric proteins containing two trimers of FasL within the same molecule. This was achieved by fusing FasL to the Fc portion of immunoglobulin G1 or to the collagen domain of ACRP30/adiponectin. Trimeric FasL and hexameric FasL both bound to Fas, but only the hexameric forms were highly cytotoxic and competent to signal apoptosis via formation of a death-inducing signaling complex. Three sequential early events in Fas-mediated apoptosis could be dissected, namely, receptor binding, receptor activation, and recruitment of intracellular signaling molecules, each of which occurred independently of the subsequent one. These results demonstrate that the limited oligomerization of FasL, and most likely of some other tumor necrosis factor family ligands such as CD40L, is required for triggering of the signaling pathways.
48
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Philipp E. Scherer, Suzanne Williams, M Fogliano et al. · Journal of Biological Chemistry · 1995 · 3.2K citations · Full text
Two CD95 (APO‐1/Fas) signaling pathways
Carsten Scaffidi · The EMBO Journal · 1998 · 3K citations · Full text
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Anders H. Berg, Terry P. Combs, Xueliang Du et al. · Nature Medicine · 2001 · 2.5K citations